Efficacy and Safety of PARP Inhibitor Combination Therapy in Recurrent Ovarian Cancer: A Systematic Review and Meta-Analysis

Efficacy and Safety of PARP Inhibitor Combination Therapy in Recurrent Ovarian Cancer: A Systematic Review and Meta-Analysis

ObjectivesThough it is known to all that PARP inhibitors (PARPis) are effective when used as maintenance alone for women with recurrent ovarian cancer (ROC), little is known about whether using them in combination with other drugs would contribute to a better efficacy. We performed a systematic revi...

Full description

Bibliographic Details
Main Authors: Ning Ren, Leyin Zhang, Jieru Yu, Siqi Guan, Xinyang Dai, Leitao Sun, Minli Ying
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
PARP inhibitor
combination therapy
monotherapy
efficacy
safety
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.638295/full

Similar Items

Similar Items